Collegium Pharmaceutical, Inc. (COLL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Collegium Pharmaceutical, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 23.35x | 13.36x | 21.57x | -31.39x | 9.13x | 25.76x |
| P/B Ratio | 4.87x | 4.04x | 5.31x | 4.03x | 3.22x | 3.70x |
| P/S Ratio | 1.88x | 1.46x | 1.83x | 1.69x | 2.36x | 2.22x |
| Profitability | ||||||
| Gross Margin | 59.3% | 59.8% | 57.5% | 45.2% | 54.4% | 58.0% |
| Operating Margin | 24.0% | 26.9% | 29.5% | 7.2% | 6.4% | 18.1% |
| Net Margin | 8.1% | 11.0% | 8.5% | -5.4% | 25.8% | 8.6% |
| EBITDA Margin | 51.4% | 54.1% | 54.4% | 37.4% | 31.3% | 38.1% |
| Liquidity | ||||||
| Current Ratio | 1.57x | 0.95x | 1.17x | 0.97x | 1.13x | 1.16x |
| Quick Ratio | 1.48x | 0.88x | 1.10x | 0.86x | 1.07x | 1.10x |
| Leverage | ||||||
| Debt/Equity | 3.12x | 3.75x | 3.45x | 3.64x | 1.28x | 1.43x |
YoY = year-over-year change. Source: FMP..